Independent research sites united under one centralized network to accelerate study start-up, enhance coordination, and strengthen community trust.
Arya Clinical was created when several high-performing research sites joined together to form a unified network in the Midwest. Each Arya Clinical site retains its established name, physician leadership, and trusted local identity while operating within a centralized organization. This model enables faster study start-up, stronger coordination across sites, and higher enrollment performance without compromising the community relationships that drive patient trust and participation.
By pairing local credibility with standardized Midwest-based infrastructure and community-based engagement, Arya Clinical accelerates trial timelines, broadens access to diverse patient populations, and delivers consistent, reliable performance across every therapeutic area the network serves.
President & CEO
Clinical Research Leader Driving High-Enrollment Operations and Strategic Growth
Medical Director
Key Opinion Leader (KOL) Physician and Rheumatology Leader with Proven Excellence in Clinical Practice and Research
Director
Syed Rajin Ahmed serves as Director at Arya Clinical, bringing extensive experience in global clinical research operations and public health leadership.
Medical Director/Investigator
Mohammed Y. Alam, MD is a distinguished physician with over 40 years of clinical experience.
Medical Director/Investigator
Suhail Khadra, MD, FACC is board certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology.
Medical Director/Investigator
Mohammad Al-Khudari, MD is a board-certified ophthalmologist and a native of Chicago’s southwest suburbs.
Medical Director/Investigator
Dr. Veena Nayak is a board-certified rheumatologist who joined the clinical research team in 2022, bringing strong clinical and research experience in complex rheumatic conditions.
Medical Director/Investigator
Sanjay Rao, MD is a board-certified, fellowship-trained cornea, cataract, and LASIK surgeon with over 20 years of experience serving the Chicagoland community.
Medical Director/Investigator
Eden Brandon, MD, FACP is a board-certified internist dedicated to providing comprehensive, patient-centered care.
Medical Director/Investigator
Norman M. James, MD, FACP is a highly regarded internal medicine physician based in Chicago, Illinois.
Medical Director/Investigator
Azazuddin A. Ahmed, MD, FACP is a board-certified internist dedicated to delivering comprehensive, patient-centered care.
MS, Six Sigma Green Belt Director of Quality Assurance
Afiya Ahmed is the Director of Quality Assurance at Arya Clinical.
Each research sites operates with its own local identity and community relationships- but together, they form the Arya Site Network. This unique model allows us to maintain the personalized care and trust of independent sites while delivering the scalability, consistency, and infrastructure of a national research organization.
611 W. Roosevelt Rd. Chicago, IL 60607
Principal Investigators:
Key Therapeutic Areas: Diabetes Mellitus Type II, Obesity, Hypertension, Hyperlipidemia, Cardiovascular & Metabolic
611 W. Roosevelt Rd. Chicago, IL 60607
Principal Investigators:
Key Therapeutic Areas: Rheumatology, Osteoarthritis, Pain Management, Men’s Health, Women’s Health, Cardiovascular & Metabolic, Infectious Disease & Vaccines, Substance Use Disorder.
3330 West 177th Street, Suite 3E Hazel Crest, IL 60429
Principal Investigators:
Key Therapeutic Areas: Diabetes Mellitus Type II, Obesity, Hypertension, Hyperlipidemia, Cardiovascular & Metabolic, Infectious Disease & Vaccines
6201 West 95th Street, Oak Lawn, IL 60453
Principal Investigators:
Key Therapeutic Area: Ophthalmology
10 Orland Square Drive, Suite 1A Orland Park, IL 60462
Principal Investigators:
Key Therapeutic Areas: Rheumatology, Osteoarthritis, Pain Management, Cardiovascular & Metabolic, Infectious Disease & Vaccines
3762 Pearl Rd., Cleveland, OH 44109
Principal Investigators:
Key Therapeutic Areas: Obesity, Hypertension, Diabetes Mellitus Type II, Migraine, Depression, Cognitive Disorders, Substance Use Disorders.
Intensive Phase 1 facility, with 10 beds, negative pressure rooms, 24 hours stay. Access to hospital within minutes.
Decisions driven by patient safety, experience, and inclusion.
Coordinating efficiently, delivering locally.
Ethical, compliant, and committed to quality.
